Cargando…
Disseminated histoplasmosis and hemophagocytic lymphohistiocytosis in a patient receiving TNF-alpha inhibitor therapy
Histoplasmosis commonly presents as an asymptomatic or self-limited infection in immunocompetent patients, but immunocompromised hosts may present with severe and disseminated disease. Herein, we present a 26-year-old male with history of ulcerative colitis receiving long-term TNF-alpha inhibitor th...
Autores principales: | Zhong, Qiaonan, Ordaya, Eloy E., Fernandez, Santiago Delgado, Lescalleet, Kristin, Larson, Daniel, Pritt, Bobbi, Berbari, Elie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418189/ https://www.ncbi.nlm.nih.gov/pubmed/36039152 http://dx.doi.org/10.1016/j.idcr.2022.e01603 |
Ejemplares similares
-
Hemophagocytic Lymphohistiocytosis and Progressive Disseminated Histoplasmosis
por: Ferguson-Paul, Kenice, et al.
Publicado: (2016) -
Disseminated histoplasmosis associated with acquired hemophagocytic lymphohistiocytosis
por: Rajput, Ashish, et al.
Publicado: (2015) -
A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis
por: Columbus-Morales, Ivan, et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis (HLH) in a Patient with Disseminated Histoplasmosis
por: Swaminathan, Neeraja, et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in Rheumatologic Disease
por: Kusne, Yael, et al.
Publicado: (2021)